| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.24 | 9e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.19 | 7e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.18 | 4e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.007 |